Cargando…

Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury

Reperfusion modality can cause damage to cardiomyocytes, known as myocardial ischemia–reperfusion injury (MI/RI). Circular RNAs (circRNAs) are fundamental regulators associated with many cardiac diseases, including MI/RI. However, their functional impact on cardiomyocyte fibrosis and apoptosis remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xi, Guo, Lei, Wang, Jingjing, Yang, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940434/
https://www.ncbi.nlm.nih.gov/pubmed/36803446
http://dx.doi.org/10.1186/s40001-023-01001-0
_version_ 1784891077254184960
author Li, Xi
Guo, Lei
Wang, Jingjing
Yang, Xing
author_facet Li, Xi
Guo, Lei
Wang, Jingjing
Yang, Xing
author_sort Li, Xi
collection PubMed
description Reperfusion modality can cause damage to cardiomyocytes, known as myocardial ischemia–reperfusion injury (MI/RI). Circular RNAs (circRNAs) are fundamental regulators associated with many cardiac diseases, including MI/RI. However, their functional impact on cardiomyocyte fibrosis and apoptosis remains elusive. Therefore, this study aimed to explore possible molecular mechanisms of circARPA1 in animal models and in hypoxia/reoxygenation (H/R)-treated cardiomyocytes. GEO dataset analysis showed that has_circ_0023461 (circARPA1) was differentially expressed in myocardial infarction samples. Real-time quantitative PCR further supported that circARPA1 was expressed at high levels in animal models and in H/R-triggered cardiomyocytes. Then, loss-of-function assays were performed to show that circARAP1 suppression effectively ameliorated cardiomyocyte fibrosis and apoptosis in MI/RI mice. Mechanistic experiments showed that miR-379-5p, KLF9 and Wnt signaling pathways were associated with circARPA1. circARPA1 can sponge miR-379-5p to regulate KLF9 expression, thereby activating the wnt/β-catenin pathway. Finally, gain-of-function assays revealed that circARAP1 aggravated MI/RI in mice and H/R-induced cardiomyocyte injury by regulating the miR-379-5p/KLF9 axis to activate Wnt/β-catenin signaling.
format Online
Article
Text
id pubmed-9940434
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99404342023-02-21 Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury Li, Xi Guo, Lei Wang, Jingjing Yang, Xing Eur J Med Res Research Reperfusion modality can cause damage to cardiomyocytes, known as myocardial ischemia–reperfusion injury (MI/RI). Circular RNAs (circRNAs) are fundamental regulators associated with many cardiac diseases, including MI/RI. However, their functional impact on cardiomyocyte fibrosis and apoptosis remains elusive. Therefore, this study aimed to explore possible molecular mechanisms of circARPA1 in animal models and in hypoxia/reoxygenation (H/R)-treated cardiomyocytes. GEO dataset analysis showed that has_circ_0023461 (circARPA1) was differentially expressed in myocardial infarction samples. Real-time quantitative PCR further supported that circARPA1 was expressed at high levels in animal models and in H/R-triggered cardiomyocytes. Then, loss-of-function assays were performed to show that circARAP1 suppression effectively ameliorated cardiomyocyte fibrosis and apoptosis in MI/RI mice. Mechanistic experiments showed that miR-379-5p, KLF9 and Wnt signaling pathways were associated with circARPA1. circARPA1 can sponge miR-379-5p to regulate KLF9 expression, thereby activating the wnt/β-catenin pathway. Finally, gain-of-function assays revealed that circARAP1 aggravated MI/RI in mice and H/R-induced cardiomyocyte injury by regulating the miR-379-5p/KLF9 axis to activate Wnt/β-catenin signaling. BioMed Central 2023-02-20 /pmc/articles/PMC9940434/ /pubmed/36803446 http://dx.doi.org/10.1186/s40001-023-01001-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Xi
Guo, Lei
Wang, Jingjing
Yang, Xing
Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury
title Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury
title_full Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury
title_fullStr Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury
title_full_unstemmed Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury
title_short Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury
title_sort pro-fibrotic and apoptotic activities of circarap1 in myocardial ischemia–reperfusion injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940434/
https://www.ncbi.nlm.nih.gov/pubmed/36803446
http://dx.doi.org/10.1186/s40001-023-01001-0
work_keys_str_mv AT lixi profibroticandapoptoticactivitiesofcircarap1inmyocardialischemiareperfusioninjury
AT guolei profibroticandapoptoticactivitiesofcircarap1inmyocardialischemiareperfusioninjury
AT wangjingjing profibroticandapoptoticactivitiesofcircarap1inmyocardialischemiareperfusioninjury
AT yangxing profibroticandapoptoticactivitiesofcircarap1inmyocardialischemiareperfusioninjury